Lack of FADD in Tie-2 expressing cells causes RIPK3-mediated embryonic lethality.

Dear Editor,

Programmed cell death has an essential role in development and homeostasis of mammalians. Fas-associated death domain (FADD) interacts with the death domain of receptors, leading to the activation of caspase-8, which subsequently activates several downstream caspases and finally executes apoptosis.[1] Ablation of Caspase-8 or Fadd resulted in embryonic lethality at around E10.5, which implicates a non-apoptosis function of these proteins in embryonic development.[2] Recently, extensively genetic studies have shown that embryonic lethality caused by Fadd (or Caspase-8) deletion can be rescued by Ripk3 or Ripk1 ablation.[2] However, it remains unclear which targeted cell type is responsible for the lethality of Fadd−/− mice.

Mice with conditional deletion of Fadd in immune cells, skin or intestine produced no lethality.[2] Given the fact that mice with Caspase-8 deficiency in endothelium, employing Tie1-cre promotor, resemble the embryonic lethality of Caspase-8 germline knockout associated with cardiac defects,[3] we hypothesized that embryonic lethality of Fadd knockout might also attribute to the loss of Fadd in endothelial cells. To directly test this hypothesis, we took advantage of the mice that expressed a functional FADD:GFP fusion gene to reconstitute Fadd−/− mice, and generated tissue-specific Fadd deletion mice using cre-recombinase under the control of tissue-specific promoter, which were reported previously.[4]

First, we specifically deleted FADD:GFP in cardiomyocytes and cardiac progenitor cells by crossing the mice (Fadd−/−Fadd:gfp+) individually with transgenic mice expressing the cTnt-cre and Nkx2.5-cre. cTnt-Cre efficiently delete target genes in myocardium and Nkx2.5-cre targets cardiomyocyte progenitors.[5, 6] We found that both Fadd−/−Fadd:gfp+cTnt-cre+ and Fadd−/−Fadd:gfp+Nkx2.5-cre+ mice develop normally at E11.5 (Figure 1a). These data indicate that it is loss of Fadd in other types of cells causing embryonic death of Fadd−/− mice, not cardiomyocytes or cardiac progenitor cells. We then generated Fadd deficiency in Tie-2 expressing cells by crossing Fadd−/−Fadd:gfp+ mice with a transgenic line that expresses cre-recombinase under the control of Tie-2 promoter. In contrast, Fadd−/−Fadd:gfp+Tie2-cre+ mice died at E11.5 with the same cardiovascular defects as Fadd−/− mice, such as vessel defect and pericardial bleeding, suggesting that hemodynamic failure resulting in embryonic death could be owing to abnormal cardiovascular development (Figure 1a). Whole-mount staining for endothelial cell marker PECAM and FADD surrogates GFP showed that FADD:GFP was expressed in endothelial cells in Fadd−/−Fadd:gfp+ mice (yellow). However, FADD:GFP was not detected in endothelial cells of Fadd+/−Fadd:gfp+Tie2-cre+ embryo (Figure 1b), whereas FADD:GFP was still expressed in non-endothelial cells such as cardiomyocytes (Figure 1b). These data indicate that Tie2-cre efficiently ablates FADD:GFP in endothelial cells. Compared with normal embryos, Fadd−/−Fadd:gfp+Tie2-cre+ displayed a low degree of trabeculation in the walls of the common ventricular chamber and endocardial cushion defect by reduced endothelial-to-mesenchymal formation (Figure 1c), suggesting that loss of Fadd in endothelial cells causes endocardium-related cardiac development defect. Although the lethality of Fadd−/−Fadd:gfp+Tie2-cre+ is caused by the same pathology as Fadd−/− embryo at E11.5,[7, 8] we asked whether this lethality of Fadd−/−Fadd:gfp+Tie2-cre+ is mediated by RIPK3 as Fadd−/− mice. Therefore, we crossed Ripk3 knockout allele to the Fadd−/−Fadd:gfp+Tie2-cre+ mice and found that embryonic lethality of Fadd−/−Fadd:gfp+Tie2-cre+ mice at E11.5 was rescued by Ripk3 deletion. Furthermore, Fadd−/−Fadd:gfp+Tie2-cre+Ripk3−/− embryos displayed normal degree of trabeculation in the walls of the common ventricular chamber and normal cushion development as Fadd−/−Fadd:gfp+ embryos (Figure 1c). Given that Tie2 is predominantly expressed in endothelial cells and hematopoietic cells, embryonic lethality of Fadd−/−Fadd:gfp+Tie2-cre+ mice at E11.5 might be owing to Fadd deletion in both endothelial and hematopoietic populations. In addition, hematopoietic stem cells are mainly derived from aortic endothelial cells during early embryonic development, and the role of FADD in hematopoietic development could also be secondary to the defect in endothelial cells. More specific genetic tools that could distinguish hematopoietic cells and endothelial cells are needed to dissect the roles of FADD in these two populations. Taken together, these results demonstrated that RIPK3-mediated signaling in Tie-2 expressing cells was responsible for the embryonic lethality of Fadd−/− with cardiac failure. Further, mechanistic study of cell death in these cell populations will be important for understanding the function of cell death during embryonic development.

Figure 1

Loss of FADD in Tie-2 expressing cells leads to embryonic lethality at E11.5 with heart defects, which can be rescued by RIPK3 knockout. (a) Whole-mount images of E11.5 embryos of the indicated genotypes. Compared with wild-type embryos, Fadd−/−Fadd:gfp+cTnt-cre+ and Fadd−/−Fadd:gfp+Nkx2.5-cre+ embryos were normal. Fadd−/−Fadd:gfp+Tie2-Cre+ embryos showed cardiovascular defects that included bleeding and pericardial edema, and no such defects were observed in Fadd−/−and Fadd−/−Fadd:gfp+Tie2-Cre+Ripk3−/− embryos. (b) Immunostaining of GFP as surrogate for FADD and endothelial cell lineage marker PECAM on embryonic heart section of the indicated genotypes. Nuclei were stained by DAPI. (c) H&E staining on E11.5 embryonic section of the indicated genotypes